Tetsuya Yagi

Prof. Dr. Tetsuya Yagi

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
KIKazuya Ichikawa
Kazuya Ichikawa
JIJakko van Ingen
Jakko van Ingen
WKWon-Jung Koh
Won-Jung Koh
DWDirk Wagner
Dirk Wagner
MSMax Salfinger
Max Salfinger
TYTetsuya Yagi
Tetsuya Yagi

13 April 2022 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Open access
KOKeisuke Oka
Keisuke Oka
AMAkane Matsumoto
Akane Matsumoto
NTNobuyuki Tetsuka
Nobuyuki Tetsuka
HMHiroshi Morioka
Hiroshi Morioka
MIMitsutaka Iguchi
Mitsutaka Iguchi
TYTetsuya Yagi
Tetsuya Yagi
The dissemination of difficult-to-treat carbapenem-resistant Enterobacterales (CRE) is of great concern. We clarified the risk factors underlying CRE infection mortality in Japan. We conducted a retrospective, multicentre, observational cohort study of patients with CRE infections at 28 university hospitals from September 2014 to December 2016, using the Japanese National Surveillance criteria. Clinical information, including patient background, type of infection, antibiotic treatment, and treatment outcome, was collected. The carbapenemase genotype was determined using PCR sequencing. Multivariate analysis was performed to identify the risk factors for 28-day mortality. Among the 179 patients enrolled, 65 patients (36.3%) had bloodstream infections, with 37 (20.7%) infections occurring due to carbapenemase-producing Enterobacterales (CPE); all carbapenemases were of IMP-type (IMP-1: 32, IMP-6: 5). Two-thirds of CPE were identified as Enterobacter cloacae complex. Combination therapy was administered only in 46 patients (25.7%), and the 28-day mortality rate was 14.3%. Univariate analysis showed that solid metastatic cancer, Charlson Comorbidity Index ≥3, bloodstream infection, pneumonia, or empyema, central venous catheters, mechanical ventilation, and prior use of quinolones were significant risk factors for mortality. Multivariate analysis revealed that mechanical ventilation (OR: 6.71 [1.42-31.6], P = 0.016), solid metastatic cancers (OR: 5.63 [1.38-23.0], P = 0.016), and bloodstream infections (OR: 3.49 [1.02-12.0], P = 0.046) were independent risk factors for 28-day mortality. The significant risk factors for 28-day mortality in patients with CRE infections in Japan are mechanical ventilation, solid metastatic cancers, and bloodstream infections.

1 January 2011 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
PDF file
IKIchiro Kawamura
Ichiro Kawamura
TYTetsuya Yagi
Tetsuya Yagi
KHKazuhito Hatakeyama
Kazuhito Hatakeyama
YHYoshinori Hasegawa
Yoshinori Hasegawa
TOTeruko Ohkura
Teruko Ohkura
SKSeiji Kojima
Seiji Kojima

24 July 2019 in Antimicrobial Resistance & Infection Control
Verified
Journal Article
Open access
PDF file
NTNobuyuki Tetsuka
Nobuyuki Tetsuka
AHAki Hirabayashi
Aki Hirabayashi
AMAkane Matsumoto
Akane Matsumoto
KOKeisuke Oka
Keisuke Oka
YHYuki Hara
Yuki Hara
TYTetsuya Yagi
Tetsuya Yagi
To clarify the molecular epidemiology of carbapenem-resistant Enterobacter cloacae complex (CREC) and the risk factors for acquisition of carbapenemase-producing E. cloacae complex (CPEC). Using clinical CREC isolates detected in a Japanese university hospital over 4 years, carbapenemase production was screened with phenotypic methods. Carbapenemase genes were analysed by PCR and sequencing. Molecular epidemiological analyses were conducted with repetitive extragenic palindromic (REP)-PCR and multilocus sequence typing (MLST). CRECs were identified to the subspecies level by hsp60 sequencing. Whole-genome sequencing of plasmids was conducted. A case-control study was performed to identify risk factors for acquisition of CPEC among patients with CREC. Thirty-nine CRECs including 20 CPECs carrying blaIMP-1 were identified. Patients with CPEC had longer hospital stay before detection (26.5 days vs. 12 days, p = 0.008), a urinary catheter (odds ratio [OR], 5.36; 95% confidence interval [CI], 1.14–30.9; p = 0.023), or intubation (OR, 7.53; 95% CI, 1.47–53.8; p = 0.008) compared to patients without CPEC. Four genetically closely related CPEC clusters were observed, which showed that three of four CPEC clusters corresponded to E. asburiae (ST 53), E. hormaechei subsp. steigerwaltii (ST 113 and ST 1047) and E. cloacae subsp. cloacae (ST 513) by MLST and hsp60 sequencing. Seven representative plasmids shared structures with class I integron containing blaIMP-1 and IncHI2A replicon type. A longer hospital stay, presence of a urinary catheter, and intubation are risk factors for CPEC acquisition. In addition to horizontal transmission of genetically indistinguishable CPECs, IncHI2A plasmid carrying blaIMP-1 appeared to be transferred among genetically different ECs.

1 February 2010 in Microbiology
Verified
Journal Article
Closed access
KIKazuya Ichikawa
Kazuya Ichikawa
TYTetsuya Yagi
Tetsuya Yagi
TITakayuki Inagaki
Takayuki Inagaki
MMMakoto Moriyama
Makoto Moriyama
TNTaku Nakagawa
Taku Nakagawa
KOKenji Ogawa
Kenji Ogawa
In addition to its known status as a disseminated disease in HIV-positive patients, Mycobacterium avium complex (MAC) is increasingly recognized as a causative pathogen of respiratory disease in HIV-negative patients. MAC is divided into Mycobacterium avium, and the less-epidemiologically studied Mycobacterium intracellulare. Genetic typing for M. intracellulare using variable number of tandem repeats (VNTR) has not yet been developed. The aim of this study was to identify VNTR loci in the genome of M. intracellulare and apply them as an epidemiological tool to clinical isolates. Here, we identified 25 VNTR loci on the M. intracellulare genome, of which 16 showed variations among clinical isolates in the number of tandem repeat motifs. Among the 74 M. intracellulare isolates, 50 genotypes were distinguished using the 16 VNTR loci, resulting in a Hunter Gaston's discriminatory index of 0.988. Moreover, all 16 VNTR loci were stable in different sets of isolates recovered within time intervals ranging from 2 to 1551 days from 14 separate patients. These results indicate that for use as epidemiological markers of M. intracellulare, the loci in this VNTR assay are highly discriminating and stable over time.

1 July 2018 in Journal of Hospital Infection
Verified
Journal Article
Closed access
HMH. Morioka
H. Morioka
MNM. Nagao
M. Nagao
SYS. Yoshihara
S. Yoshihara
HOH. Ohge
H. Ohge
KKK. Kasahara
K. Kasahara
TYTetsuya Yagi
Tetsuya Yagi